Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hospital-Acquired Infection Diagnostics Market, by Product
1.4.2 North America Hospital-Acquired Infection Diagnostics Market, by Infection Type
1.4.3 North America Hospital-Acquired Infection Diagnostics Market, by Application
1.4.4 North America Hospital-Acquired Infection Diagnostics Market, by Test Type
1.4.5 North America Hospital-Acquired Infection Diagnostics Market, by End User
1.4.6 North America Hospital-Acquired Infection Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. North America Hospital-Acquired Infection Diagnostics Market by Product
4.1 North America Reagents & Consumables Market by Country
4.2 North America Instrument Market by Country
Chapter 5. North America Hospital-Acquired Infection Diagnostics Market by Infection Type
5.1 North America Urinary Tract Infections (UTI) Market by Country
5.2 North America Hospital Acquired Pneumonia Market by Country
5.3 North America Bloodstream Infections Market by Country
5.4 North America Surgical Site Infections Market by Country
5.5 North America Gastrointestinal Infections Market by Country
5.6 North America Others Market by Country
Chapter 6. North America Hospital-Acquired Infection Diagnostics Market by Application
6.1 North America Drug-Resistance Testing Market by Country
6.2 North America Disease Testing Market by Country
Chapter 7. North America Hospital-Acquired Infection Diagnostics Market by Test Type
7.1 North America Molecular Diagnostics Market by Country
7.2 North America Immunoassay Market by Country
7.3 North America Urinalysis Market by Country
Chapter 8. North America Hospital-Acquired Infection Diagnostics Market by End User
8.1 North America Hospital Market by Country
8.2 North America Standalone Laboratories Market by Country
8.3 North America Others Market by Country
Chapter 9. North America Hospital-Acquired Infection Diagnostics Market by Country
9.1 US Hospital-Acquired Infection Diagnostics Market
9.1.1 US Hospital-Acquired Infection Diagnostics Market by Product
9.1.2 US Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.3 US Hospital-Acquired Infection Diagnostics Market by Application
9.1.4 US Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.5 US Hospital-Acquired Infection Diagnostics Market by End User
9.2 Canada Hospital-Acquired Infection Diagnostics Market
9.2.1 Canada Hospital-Acquired Infection Diagnostics Market by Product
9.2.2 Canada Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.3 Canada Hospital-Acquired Infection Diagnostics Market by Application
9.2.4 Canada Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.5 Canada Hospital-Acquired Infection Diagnostics Market by End User
9.3 Mexico Hospital-Acquired Infection Diagnostics Market
9.3.1 Mexico Hospital-Acquired Infection Diagnostics Market by Product
9.3.2 Mexico Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.3 Mexico Hospital-Acquired Infection Diagnostics Market by Application
9.3.4 Mexico Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.5 Mexico Hospital-Acquired Infection Diagnostics Market by End User
9.4 Rest of North America Hospital-Acquired Infection Diagnostics Market
9.4.1 Rest of North America Hospital-Acquired Infection Diagnostics Market by Product
9.4.2 Rest of North America Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.3 Rest of North America Hospital-Acquired Infection Diagnostics Market by Application
9.4.4 Rest of North America Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.5 Rest of North America Hospital-Acquired Infection Diagnostics Market by End User
Chapter 10. Company Profiles
10.1 Bayer AG (Bayer Schering Pharma AG)
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent Strategies and Developments
10.1.5.1 Partnerships, Collaborations and Agreements
10.2 Danaher Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.3 Becton, Dickinson and Company
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.1 Recent Strategies and Developments
10.3.1.1 Partnerships, Collaborations and Agreements
10.3.1.2 Product Launches and Product Expansions
10.4 Hologic, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent Strategies and Developments
10.4.5.1 Partnerships, Collaborations and Agreements
10.4.5.2 Product Launches and Product Expansions
10.5 Ecolab, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent Strategies and Developments
10.5.5.1 Product Launches and Product Expansions:
10.5.5.2 Geographical Expansions:
10.6 Pfizer, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Regional & Segmental Analysis
10.6.4 Research & Development Expense
10.6.5 Recent Strategies and Developments
10.6.5.1 Approvals and Trials:
10.6.5.2 Acquisitions and Mergers
10.7 Steris PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.8 Johnson & Johnson
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental &Regional Analysis
10.8.4 Research & Development Expenses
10.9 Abbott Laboratories
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent Strategies and Developments
10.9.5.1 Approvals and Trials:
10.9.5.2 Product Launches and Product Expansions:
10.10. Merck Group
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent Strategies and Developments
10.10.5.1 Partnerships, Collaborations and Agreements
Unique Offerings 